You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms, Plasma Cell

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Boston (THRIVE-M)

Not yet recruiting
  • Multiple Myeloma
  • THRIVE-M
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 2, 2023

Multiple Myeloma Trial in Tucson (Immediate yoga intervention, Delayed yoga intervention)

Not yet recruiting
  • Multiple Myeloma
  • Immediate yoga intervention
  • Delayed yoga intervention
  • Tucson, Arizona
    University of Arizona Cancer Center
Sep 27, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Carfilzomib, Cyclophosphamide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Jun 8, 2023

Relapsed or Refractory Multiple Myeloma Trial in Tianjin (YTS104 Cells injection)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • YTS104 Cells injection
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 13, 2023

Hypoxia and the Immune Environment in Myeloma Patients (CHIME)

Not yet recruiting
  • Myeloma
    • Manchester, Greater Manchester, United Kingdom
      The Christie NHS Foundation Trust
    Aug 16, 2023

    Relapsed or Refractory Multiple Myeloma Trial (Talquetamab)

    Available
    • Relapsed or Refractory Multiple Myeloma
    • (no location specified)
    Mar 6, 2023

    Multiple Myeloma Trial in Zwolle (e-coach multipel myeloma (MM))

    Recruiting
    • Multiple Myeloma
    • e-coach multipel myeloma (MM)
    • Zwolle, Overijssel, Netherlands
      Isala Klinieken
    Jul 26, 2023

    Optical Genome Mapping in Characterization of Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Bone Marrow samples collection
    • Strasbourg, France
      Institut de cancérologie Strasbourg Europe
    Mar 15, 2023

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Lymphoma, Non-Hodgkin, Myeloma Multiple Trial (Connected scale "Body Comp Pro" from Withings)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • Myeloma Multiple
    • Connected scale "Body Comp Pro" from Withings
    • (no location specified)
    Nov 9, 2023

    Stem Cells Mobilization, colLection and Engraftment in Newly

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Rome, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Apr 28, 2023

    Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

    Completed
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Myeloma Coach or CLL Coach Mobile App
    • Springboard Beyond Cancer informational website
    • Durham, North Carolina
      Duke University
    Jun 23, 2023

    Multiple Myeloma Trial in Houston (Belantamab mafodotin)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 5, 2023

    Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Radiation Therapy
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • APRIL-BAFF-Bicephali CAR-T cells
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 14, 2023

    Multiple Myeloma Trial in Roma, Rome (ATAC-seq and ChIP-seq)

    Recruiting
    • Multiple Myeloma
    • ATAC-seq and ChIP-seq
    • Roma, Italy
    • +1 more
    May 4, 2023

    Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

    Not yet recruiting
    • Relapsed/ Refractory Multiple Myeloma
    • GC012F
    • (no location specified)
    Apr 28, 2023

    Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Discontinuation of maintenance treatment
    • Cork, Ireland
      Cork University Hospital
    May 10, 2023

    Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

    Not yet recruiting
    • Multiple Myeloma
    • Stem Cell Transplant Complications
    • PARE
    • Waitlist Control Group
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 30, 2023

    Multiple Myeloma Trial in Canton (Lenalidomide)

    Recruiting
    • Multiple Myeloma
    • Canton, Ohio
      Gabrail Cancer & Research Center
    Oct 11, 2023

    Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

    Not yet recruiting
    • Lymphoma
    • +2 more
    • Web Application
    • San Francisco, California
      University of California, San Francisco
    Oct 4, 2022

    Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)

    Recruiting
    • Neoplasm, Plasma Cell
    • Lymphoma
    • Comprehensive Geriatric Assessment
    • Toulouse, France
      University Hospital Toulouse
    Oct 12, 2022

    Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)

    Completed
    • Non-Hodgkin's Lymphoma
    • Plasma Cell Myeloma
    • Hematopoietic Cell Transplantation
    • +2 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Nov 16, 2022

    Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial in Wuhan (CAR-T (CAR-GPRC5D))

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Plasma Cell Leukemia
    • CAR-T (CAR-GPRC5D)
    • Wuhan, Hu Bei, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    May 17, 2022

    Chemo-induced Peripheral Neuropathy, Plasma Cell Myeloma Trial in Winston-Salem (VascuTherm5 vascular compression device)

    Recruiting
    • Chemotherapy-induced Peripheral Neuropathy
    • Plasma Cell Myeloma
    • VascuTherm5 vascular compression device
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Dec 16, 2022